How Much Erlotinib Daily for EGFR Mutation Cancer?

So, Erlotinib is this EGFR inhibitor that’s actually approved for treating two types of cancer – NSCLC and pancreatic cancer – in people who have EGFR mutations. It’s like it stops this EGFR signaling pathway from doing its thing. You can get this drug in three different dosages: 25 mg, 100 mg, and the highest is 150 mg.

For grown-ups, the recommended dose is 150 mg, and it’s best to take it once a day on an empty tummy. Each bottle’s got 30 tablets, and they’re all film-coated for easy swallowing. The main stuff in Erlotinib is erlotinib hydrochloride, and it’s a type of tyrosine kinase inhibitor.

It’s really crucial to stick to the dosing plan so that it works super well and doesn’t cause too many side effects.